96 related articles for article (PubMed ID: 20811716)
1. TrkB antibody elicits cytotoxicity and suppresses migration/invasion of transitional cell carcinoma cells.
Huang YT; Lai PC; Wu CC; Cheng CC; Chiu TH
Int J Oncol; 2010 Oct; 37(4):943-9. PubMed ID: 20811716
[TBL] [Abstract][Full Text] [Related]
2. BDNF mediated TrkB activation is a survival signal for transitional cell carcinoma cells.
Huang YT; Lai PC; Wu CC; Hsu SH; Cheng CC; Lan YF; Chiu TH
Int J Oncol; 2010 Jun; 36(6):1469-76. PubMed ID: 20428771
[TBL] [Abstract][Full Text] [Related]
3. Therapeutic potential of sepantronium bromide YM155 in gemcitabine-resistant human urothelial carcinoma cells.
Huang YT; Cheng CC; Lin TC; Chiu TH; Lai PC
Oncol Rep; 2014 Feb; 31(2):771-80. PubMed ID: 24297644
[TBL] [Abstract][Full Text] [Related]
4. Brain-derived neurotrophic factor/tropomyosin-related kinase B signaling pathway contributes to the aggressive behavior of lung squamous cell carcinoma.
Ozono K; Ohishi Y; Onishi H; Nakamura K; Motoshita J; Kato M; Nakanishi R; Nakamura M; Oda Y
Lab Invest; 2017 Nov; 97(11):1332-1342. PubMed ID: 28604655
[TBL] [Abstract][Full Text] [Related]
5. BDNF activates TrkB/PLCγ1 signaling pathway to promote proliferation and invasion of ovarian cancer cells through inhibition of apoptosis.
Xu Y; Jiang WG; Wang HC; Martin T; Zeng YX; Zhang J; Qi YS
Eur Rev Med Pharmacol Sci; 2019 Jun; 23(12):5093-5100. PubMed ID: 31298409
[TBL] [Abstract][Full Text] [Related]
6. Overexpression of BDNF and TrkB in human bladder cancer specimens.
Lai PC; Chiu TH; Huang YT
Oncol Rep; 2010 Nov; 24(5):1265-70. PubMed ID: 20878119
[TBL] [Abstract][Full Text] [Related]
7. Sunitinib can enhance BCG mediated cytotoxicity to transitional cell carcinoma through apoptosis pathway.
Ping SY; Wu CL; Yu DS
Urol Oncol; 2012 Sep; 30(5):652-9. PubMed ID: 20884251
[TBL] [Abstract][Full Text] [Related]
8. Treatment with low-dose interferon-alpha restores the balance between matrix metalloproteinase-9 and E-cadherin expression in human transitional cell carcinoma of the bladder.
Slaton JW; Karashima T; Perrotte P; Inoue K; Kim SJ; Izawa J; Kedar D; McConkey DJ; Millikan R; Sweeney P; Yoshikawa C; Shuin T; Dinney CP
Clin Cancer Res; 2001 Sep; 7(9):2840-53. PubMed ID: 11555602
[TBL] [Abstract][Full Text] [Related]
9. Upregulation of the BDNF/TrKB pathway promotes epithelial-mesenchymal transition, as well as the migration and invasion of cervical cancer.
Yuan Y; Ye HQ; Ren QC
Int J Oncol; 2018 Feb; 52(2):461-472. PubMed ID: 29345295
[TBL] [Abstract][Full Text] [Related]
10. GZD2202, a novel TrkB inhibitor, suppresses BDNF-mediated proliferation and metastasis in neuroblastoma models.
Zou J; Zhang Z; Xu F; Cui S; Qi C; Luo J; Wang Z; Lu X; Tu Z; Ren X; Song L; Ding K
J Drug Target; 2019 Apr; 27(4):442-450. PubMed ID: 30301369
[TBL] [Abstract][Full Text] [Related]
11. Effects of YC-1 on hypoxia-inducible factor 1 alpha in hypoxic human bladder transitional carcinoma cell line T24 cells.
Li Y; Zhao X; Tang H; Zhong Z; Zhang L; Xu R; Li S; Wang Y
Urol Int; 2012; 88(1):95-101. PubMed ID: 22041818
[TBL] [Abstract][Full Text] [Related]
12. Oxaliplatin down-regulates survivin by p38 MAP kinase and proteasome in human colon cancer cells.
Liu HF; Hu HC; Chao JI
Chem Biol Interact; 2010 Dec; 188(3):535-45. PubMed ID: 20708607
[TBL] [Abstract][Full Text] [Related]
13. Tissue microarray analysis of the prognostic value of E-cadherin, Ki67, p53, p27, survivin and MSH2 expression in upper urinary tract transitional cell carcinoma.
Fromont G; Rouprêt M; Amira N; Sibony M; Vallancien G; Validire P; Cussenot O
Eur Urol; 2005 Nov; 48(5):764-70. PubMed ID: 16126329
[TBL] [Abstract][Full Text] [Related]
14. Immunohistochemical localization of the IAP protein survivin in bladder mucosa and transitional cell carcinoma.
Lehner R; Lucia MS; Jarboe EA; Orlicky D; Shroyer AL; McGregor JA; Shroyer KR
Appl Immunohistochem Mol Morphol; 2002 Jun; 10(2):134-8. PubMed ID: 12051631
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of tropomyosine receptor kinase B on the migration of human Schwann cell and dispersion of oral tongue squamous cell carcinoma in vitro.
Ein L; Bracho O; Mei C; Patel J; Boyle T; Monje P; Fernandez-Valle C; Bas E; Thomas G; Weed D; Sargi Z; Dinh C
Head Neck; 2019 Dec; 41(12):4069-4075. PubMed ID: 31497919
[TBL] [Abstract][Full Text] [Related]
16. TrkB/BDNF signaling pathway is a potential therapeutic target for pulmonary large cell neuroendocrine carcinoma.
Odate S; Nakamura K; Onishi H; Kojima M; Uchiyama A; Nakano K; Kato M; Tanaka M; Katano M
Lung Cancer; 2013 Mar; 79(3):205-14. PubMed ID: 23312550
[TBL] [Abstract][Full Text] [Related]
17. Evodiamine inhibits the migration and invasion of nasopharyngeal carcinoma cells in vitro via repressing MMP-2 expression.
Peng X; Zhang Q; Zeng Y; Li J; Wang L; Ai P
Cancer Chemother Pharmacol; 2015 Dec; 76(6):1173-84. PubMed ID: 26546460
[TBL] [Abstract][Full Text] [Related]
18. [Effects of tyrosine kinase receptor B and brain-derived neurotrophic factor on chemoresistance in neuroblastoma].
Li AM; Zhang JH; Zhang JH; Zhang KR; Rong DJ
Zhonghua Er Ke Za Zhi; 2006 Jul; 44(7):535-9. PubMed ID: 17044982
[TBL] [Abstract][Full Text] [Related]
19. Design, synthesis and biological evaluation of 3-(imidazo[1,2-a]pyrazin-3-ylethynyl)-2-methylbenzamides as potent and selective pan-tropomyosin receptor kinase (TRK) inhibitors.
Cui S; Wang Y; Wang Y; Tang X; Ren X; Zhang L; Xu Y; Zhang Z; Zhang ZM; Lu X; Ding K
Eur J Med Chem; 2019 Oct; 179():470-482. PubMed ID: 31271959
[TBL] [Abstract][Full Text] [Related]
20. Brain-derived neurotrophic factor activation of TrkB protects neuroblastoma cells from chemotherapy-induced apoptosis via phosphatidylinositol 3'-kinase pathway.
Jaboin J; Kim CJ; Kaplan DR; Thiele CJ
Cancer Res; 2002 Nov; 62(22):6756-63. PubMed ID: 12438277
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
